Purchase Order HHSN272201501275P
- Not listed
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award, valued at $5,277.25, is for the provision of sequencing kits to support NIAID's research and diagnostics work. Illumina has been a long-standing provider of sequencing solutions to various federal agencies including the Centers for...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,552.00. The award is not associated with a set-aside program. Illumina, a manufacturer of genetic sequencing systems and reagents, has provided similar products and services to support genomic sequencing and analysis for research and diagnostics across multiple federal agencies in the past. This...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Illumina, Inc. The $5,006.36 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services and support to support genomic sequencing and analysis, with no set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
- This is a $8,080.64 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is not associated with a set-aside program. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and diagnostics for various federal agencies including the NIH, CDC, USDA, and VA. This particular...
- This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $5,212.06 contract is for the provision of next-generation sequencing kits to support genomic research and diagnostics. Illumina has a history of providing sequencing systems, reagents, and associated services to federal agencies including the NIH, Centers for Disease Control, Department of Agriculture, and Department of Veterans Affairs. This award did not use a set-aside designation. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy's Bureau of Medicine and Surgery to provide sequencing platforms and consumables for biothreats characterization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $100 | 9/10/15 | |
| Not listed | Not listed | $5.1k | 9/4/15 |